Cypress Capital Management LLC Merck & Co., Inc. Transaction History

Cypress Capital Management LLC

$0
Q4 2022

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	SELL	$84.53 - $94.96 $2.64 Million - $2.97 Million	-31,279 Reduced 14.01%	191,976 $16.5 Million
Q2 2022 Aug 10, 2022	SELL	$83.49 - $94.64 $68,461 - $77,604	-820 Reduced 0.37%	223,255 $20.4 Million
Q1 2022 May 13, 2022	SELL	$73.51 - $82.4 $825,958 - $925,846	-11,236 Reduced 4.77%	224,075 $18.4 Million
Q4 2021 Feb 22, 2022	BUY	$72.28 - $90.54 $342,173 - $428,616	4,734 Added 2.05%	235,311 $18 Million
Q2 2021 Aug 12, 2021	BUY	$70.31 - $77.77 $114,956 - $127,153	1,635 Added 0.71%	230,577 $17.9 Million
Q1 2021 May 12, 2021	SELL	$68.86 - $81.11 $1.34 Million - $1.57 Million	-19,403 Reduced 7.81%	228,942 $17.6 Million
Q4 2020 Feb 08, 2021	SELL	$71.77 - $79.65 $806,335 - $894,867	-11,235 Reduced 4.33%	248,345 $20.3 Million
Q3 2020 Nov 12, 2020	BUY	$73.18 - $82.95 $95,499 - $108,249	1,305 Added 0.51%	259,580 $21.5 Million
Q2 2020 Aug 13, 2020	SELL	$70.42 - $80.13 $117,601 - $133,817	-1,670 Reduced 0.64%	258,275 $20 Million
Q1 2020 Apr 24, 2020	SELL	$63.36 - $87.82 $262,310 - $363,574	-4,140 Reduced 1.57%	259,945 $20 Million
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $70,209 - $79,223	-905 Reduced 0.34%	264,085 $24 Million
Q3 2019 Nov 01, 2019	BUY	$76.08 - $82.93 $2.81 Million - $3.07 Million	36,978 Added 16.22%	264,990 $22.3 Million
Q2 2019 Aug 05, 2019	SELL	$69.84 - $81.59 $1.86 Million - $2.17 Million	-26,568 Reduced 10.44%	228,012 $13.1 Million
Q2 2019 Aug 05, 2019	BUY	$69.84 - $81.59 $261,900 - $305,962	3,750 Added 1.5%	254,580 $21.3 Million
Q1 2019 May 06, 2019	SELL	$69.58 - $79.36 $3.61 Million - $4.11 Million	-51,815 Reduced 17.12%	250,830 $20.9 Million
Q4 2018 Feb 05, 2019	SELL	$65.24 - $75.71 $112,669 - $130,751	-1,727 Reduced 0.57%	302,645 $23.1 Million
Q3 2018 Nov 09, 2018	SELL	$57.69 - $67.84 $302,814 - $356,092	-5,249 Reduced 1.7%	304,372 $21.6 Million
Q2 2018 Aug 03, 2018	BUY	$50.83 - $59.72 $772,616 - $907,744	15,200 Added 5.16%	309,621 $18.8 Million
Q1 2018 May 04, 2018	SELL	$50.96 - $59.23 $73,382 - $85,291	-1,440 Reduced 0.49%	294,421 $16 Million
Q4 2017 Feb 07, 2018	BUY	$51.62 - $61.64 $2.22 Million - $2.64 Million	42,910 Added 16.96%	295,861 $16.6 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $176,010 - $189,390	3,000 Added 1.2%	252,951 $16.2 Million
Q2 2017 Aug 15, 2017	BUY	N/A	249,951	249,951 $16 Million

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

Vanguard Group Inc Valley Forge, PA

250M
Shares

$25.8 Billion
0.52% of portfolio
Black Rock Inc. New York, NY

207M
Shares

$21.4 Billion
0.59% of portfolio
State Street Corp Boston, MA

119M
Shares

$12.3 Billion
0.56% of portfolio
Wellington Management Group LLP Boston, MA

75.8M
Shares

$7.82 Billion
1.55% of portfolio
Geode Capital Management, LLC Boston, MA

59.2M
Shares

$6.1 Billion
0.55% of portfolio

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital Management LLC with notifications on news.

Account